Names | |
---|---|
IUPAC name
Methyl (E)-2-[(2S,3S,7aS,12bS)-3-ethyl-7a-hydroxy-8-methoxy-2,3,4,6,7,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate
|
|
Other names
7α-Hydroxy-7H-mitragynine; 9-Methoxycorynantheidine hydroxyindolenine
|
|
Identifiers | |
174418-82-7 | |
3D model (Jmol) |
Interactive image Interactive image |
ChEMBL | ChEMBL61630 |
ChemSpider | 23152144 |
PubChem | 44301524 |
UNII | 2T3TWA75R0 |
|
|
|
|
Properties | |
C23H30N2O5 | |
Molar mass | 414.50 g·mol−1 |
log P | 1.266 |
Acidity (pKa) | 12.203 |
Basicity (pKb) | 1.794 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
what is ?) | (|
Infobox references | |
7-Hydroxymitragynine is a terpenoid indole alkaloid from the plant Mitragyna speciosa, commonly known as Kratom. In mice, it is orally active and has analgesic effects.
7-Hydroxymitragynine is a partial agonist at the μ-opioid receptor with a potency, calculated using pD (2) values, that is 30-fold higher than that of mitragynine and 17-fold higher than that of morphine, respectively. As a G protein biased ligand at this receptor it causes significantly less side effects than morphine, like constipation, development of tolerance and withdrawal syndrome upon abstinence. The O-acetyl ester (Acetoxy), 7-acetoxymitragynine has also been reported and found to be an active μ-opioid agonist.